Novartis to expand oncology portfolio with acquisition of Mariana Oncology

Pallavi Madhiraju- May 2, 2024 0

Novartis has announced a significant move in the oncology sector with its agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts. ... Read More

ANGLE plc collaborates with AstraZeneca on cutting-edge cancer detection technology

Pallavi Madhiraju- April 29, 2024 0

ANGLE plc, a leading innovator in liquid biopsy and circulating tumour cell (CTC) solutions, has announced a significant supplier agreement with global biopharmaceutical leader AstraZeneca ... Read More

Ascentage Pharma showcases novel drug candidates at AACR 2024

Pallavi Madhiraju- April 8, 2024 0

Ascentage Pharma (6855.HK), a prominent global biopharmaceutical firm, recently unveiled the latest preclinical study results for its innovative drug candidates at the American Association of ... Read More

Genmab to acquire ProfoundBio in $1.8bn deal to enhance cancer treatment

Pallavi Madhiraju- April 3, 2024 0

In a landmark move within the biotechnology sector, Genmab A/S (Nasdaq: GMAB) and ProfoundBio, Inc. have announced a definitive agreement under which Genmab will acquire ... Read More

Bristol Myers Squibb announces success of KRAZATI in Phase 3 KRYSTAL-12 study

Pallavi Madhiraju- April 1, 2024 0

Bristol Myers Squibb (NYSE: BMY) has reached a pivotal milestone in the treatment of non-small cell lung cancer (NSCLC) with its announcement regarding the KRYSTAL-12 ... Read More

Kate Middleton announces preventative chemotherapy following cancer discovery

Pallavi Madhiraju- March 23, 2024 0

Kate Middleton, the Princess of Wales, has publicly disclosed her ongoing preventative chemotherapy treatment after a major abdominal surgery in January unveiled the presence of ... Read More

AstraZeneca to acquire Fusion Pharmaceuticals to boost cancer radioconjugate development

Pallavi Madhiraju- March 19, 2024 0

In a strategic move to revolutionize cancer treatment, AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals Inc., a pioneer in the development of ... Read More

FDA approves BeiGene’s TEVIMBRA for esophageal cancer treatment

Pallavi Madhiraju- March 18, 2024 0

In a notable advancement in the oncology sector, BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a globally recognized oncology company, has received approval from ... Read More

GE HealthCare, Elekta join forces to enhance cancer treatment in India

Pallavi Madhiraju- July 7, 2023 0

GE HealthCare, a prominent global player in the medical technology and diagnostics sector, is broadening its partnership with Elekta, a leading name in radiation therapy, ... Read More

Yashoda Hospital, Elekta introduce Unity MR Linac for cancer treatment

Pallavi Madhiraju- June 23, 2023 0

Yashoda Hospital, in partnership with Elekta, a Swedish developer of precision radiation therapy, has introduced the latter’s Unity MR Linac system in India, marking a ... Read More